Sponsor:
A2 Biotherapeutics Inc.
Code:
NCT04981119
Conditions
Solid Tumor, Adult
Colorectal Cancer
Non Small Cell Lung Cancer
Pancreatic Cancer
CRC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Apheresis
Next Generation Sequencing (NGS)
Long Range NGS HLA typing
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by A2 Biotherapeutics Inc. on 2025-09-08.